Dementia Research Today is a free monthly online journal that collates and summarizes the latest research about Dementia, including details on symptoms, alzheimers, senile dementia, causes.

Volume 7 (2010), Issue 1 (January)

1. Interaction of double-stranded RNA-dependent protein kinase (PKR) with the death receptor signaling pathway in amyloid beta (Abeta)-treated cells and in APPSLPS1 knock-in mice.
   J Biol Chem, 285(2): 1272-82. [Abstract] [Full-text]
2. Semantic dementia: demography, familial factors and survival in a consecutive series of 100 cases.
   Brain, 133: 300-6. [Abstract] [Full-text]
3. Non-verbal sound processing in the primary progressive aphasias.
   Brain, 133: 272-85. [Abstract] [Full-text]
4. Language networks in semantic dementia.
   Brain, 133: 286-99. [Abstract] [Full-text]
5. A fragment of the scaffolding protein RanBP9 is increased in Alzheimer's disease brains and strongly potentiates amyloid-beta peptide generation.
   FASEB J, 24(1): 119-27. [Abstract] [Full-text]
6. Many neuronal and behavioral impairments in transgenic mouse models of Alzheimer's disease are independent of caspase cleavage of the amyloid precursor protein.
   J Neurosci, 30(1): 372-81. [Abstract] [Full-text]
7. Metabotropic glutamate receptor-mediated cell signaling pathways are altered in a mouse model of Huntington's disease.
   J Neurosci, 30(1): 316-24. [Abstract] [Full-text]
8. Neuroprotective activities of CEP-1347 in models of neuroAIDS.
   J Immunol, 184(2): 746-56. [Abstract] [Full-text]
9. Redox proteomic analysis of carbonylated brain proteins in mild cognitive impairment and early Alzheimer's disease.
   Antioxid Redox Signal, 12(3): 327-36. [Abstract] [Full-text]
10. Donepezil treatment and changes in hippocampal structure in very mild Alzheimer disease.
    Arch Neurol, 67(1): 99-106. [Abstract] [Full-text]
11. APOE epsilon4 genotype and longitudinal changes in cerebral blood flow in normal aging.
    Arch Neurol, 67(1): 93-8. [Abstract] [Full-text]
12. Physical exercise, aging, and mild cognitive impairment: a population-based study.
    Arch Neurol, 67(1): 80-6. [Abstract] [Full-text]
13. Effects of aerobic exercise on mild cognitive impairment: a controlled trial.
    Arch Neurol, 67(1): 71-9. [Abstract] [Full-text]
14. Homocysteine levels in chronic gastritis and other conditions: relations to incident cardiovascular disease and dementia.
    Dig Dis Sci, 55(2): 351-8. [Abstract] [Full-text]
15. Association of a functional polymorphism in the cholesteryl ester transfer protein (CETP) gene with memory decline and incidence of dementia.
    JAMA, 303(2): 150-8. [Abstract] [Full-text]
16. Olfactory dysfunction correlates with amyloid-beta burden in an Alzheimer's disease mouse model.
    J Neurosci, 30(2): 505-14. [Abstract] [Full-text]
17. Support for a tax increase to provide unrestricted access to an Alzheimer's disease medication: a survey of the general public in Canada.
    BMC Health Serv Res, 9: 246. [Abstract] [Full-text]
18. Switching from oral cholinesterase inhibitors to the rivastigmine transdermal patch.
    CNS Neurosci Ther, 16(1): 51-60. [Abstract] [Full-text]
19. Anesthetic management of patients with Huntington disease.
    Anesth Analg, 110(2): 515-23. [Abstract] [Full-text]
20. Neurodegeneration in an Abeta-induced model of Alzheimer's disease: the role of Cdk5.
    Aging Cell, 9(1): 64-77. [Abstract] [Full-text]
21. Inhaled anesthetic potency in aged Alzheimer mice.
    Anesth Analg, 110(2): 427-30. [Abstract] [Full-text]
22. Transgenic Alzheimer mice have a larger minimum alveolar anesthetic concentration of isoflurane than their nontransgenic littermates.
    Anesth Analg, 110(2): 438-41. [Abstract] [Full-text]
23. Anesthesia and the old brain.
    Anesth Analg, 110(2): 421-6. [Abstract] [Full-text]
24. Effect of cognitive fluctuation on neuropsychological performance in aging and dementia.
    Neurology, 74(3): 210-7. [Abstract] [Full-text]
25. Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization.
    Neurology, 74(3): 201-9. [Abstract] [Full-text]
26. Exaggerated inflammation, impaired host defense, and neuropathology in progranulin-deficient mice.
    J Exp Med, 207(1): 117-28, S1-4. [Abstract] [Full-text]
27. Up-regulation of the type 3 ryanodine receptor is neuroprotective in the TgCRND8 mouse model of Alzheimer's disease.
    J Neurochem, 112(2): 356-65. [Abstract] [Full-text]
28. Disease-toxicant screen reveals a neuroprotective interaction between Huntington's disease and manganese exposure.
    J Neurochem, 112(1): 227-37. [Abstract] [Full-text]
29. Blood levels of kynurenines, interleukin-23 and soluble human leucocyte antigen-G at different stages of Huntington's disease.
    J Neurochem, 112(1): 112-22. [Abstract] [Full-text]
30. Alzheimer's beta-amyloid peptide blocks vascular endothelial growth factor mediated signaling via direct interaction with VEGFR-2.
    J Neurochem, 112(1): 66-76. [Abstract] [Full-text]
31. Involvement of peptidylarginine deiminase-mediated post-translational citrullination in pathogenesis of sporadic Creutzfeldt-Jakob disease.
    Acta Neuropathol, 119(2): 199-210. [Abstract] [Full-text]
32. Imipramine, in part through tumor necrosis factor alpha inhibition, prevents cognitive decline and beta-amyloid accumulation in a mouse model of Alzheimer's disease.
    J Pharmacol Exp Ther, 332(2): 505-14. [Abstract] [Full-text]
33. Deficient high-affinity binding of Pittsburgh compound B in a case of Alzheimer's disease.
    Acta Neuropathol, 119(2): 221-33. [Abstract] [Full-text]
34. Sulfation of heparan sulfate associated with amyloid-beta plaques in patients with Alzheimer's disease.
    Acta Neuropathol, 119(2): 211-20. [Abstract] [Full-text]
35. Secondhand smoke, vascular disease, and dementia incidence: findings from the cardiovascular health cognition study.
    Am J Epidemiol, 171(3): 292-302. [Abstract] [Full-text]
36. Factor analysis of proton MR spectroscopic imaging data in HIV infection: metabolite-derived factors help identify infection and dementia.
    Radiology, 254(2): 577-86. [Abstract] [Full-text]
37. Structural correlates of antibodies associated with acute reversal of amyloid beta-related behavioral deficits in a mouse model of Alzheimer disease.
    J Biol Chem, 285(5): 3417-27. [Abstract] [Full-text]
38. HIF prolyl hydroxylase inhibitors prevent neuronal death induced by mitochondrial toxins: therapeutic implications for Huntington's disease and Alzheimer's disease.
    Antioxid Redox Signal, 12(4): 435-43. [Abstract] [Full-text]
39. Bone marrow-derived progenitor cells in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy.
    Stroke, 41(2): 218-23. [Abstract] [Full-text]
40. Triazole-containing BODIPY dyes as novel fluorescent probes for soluble oligomers of amyloid Abeta1-42 peptide.
    Biochem Biophys Res Commun, 391(3): 1455-8. [Abstract] [Full-text]

© 2004-2012 Dementia Research Today. All Rights Reserved.